Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-01-25

FDA Approved: OXYTROL FOR WOMEN — Original Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved OXYTROL FOR WOMEN (oxybutynin) under Allergan's original application. It is indicated for urinary symptoms associated with overactive bladder i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXYTROL FOR WOMEN (OXYBUTYNIN)

Snippet

ORIG AP for OXYTROL FOR WOMEN (OXYBUTYNIN)